6th Edition of Euro-Global Conference on Biotechnology and Bioengineering
September 28-30 | Hybrid Event
Gene Therapy & RNA Therapeutics
Gene Therapy & RNA Therapeutics are redefining the future of disease treatment by targeting conditions at their genetic root. Gene therapy introduces functional genes into patients' cells to correct genetic mutations, using viral or non-viral vectors to deliver therapeutic DNA. Simultaneously, RNA-based drugs—such as siRNA, mRNA, and antisense oligonucleotides—are being used to silence, replace, or modulate gene expression with high specificity. Recent advances include mRNA vaccines and gene-editing platforms like CRISPR for correcting single-gene disorders. Gene Therapy & RNA Therapeutics are proving effective against cancer, rare genetic diseases, and neurodegenerative disorders. As delivery mechanisms and regulatory frameworks evolve, these molecular approaches are becoming more accessible and personalized, with potential to revolutionize preventive, curative, and precision medicine.
Narendra Chirmule
Indian Institute of Technology (IIT), India
Thomas J Webster
Brown University, United States
Babak Faramarzi
Western University of Health Sciences, United States
Md Monir Hossain
RMIT University, Australia
K R Aneja
Kurukshetra University, India
Santosh Kumar Mishra
S.N.D.T. Women's University (Retired), India
Koustav Sarkar
SRM Institute of Science and Technology, IndiaSubmit your abstract Today
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Steps and strides: Cross-species insights into movement and injury
Babak Faramarzi, Western University of Health Sciences, United States
Title : Eliminating implant failure in humans with nano chemistry: 45,000 cases and counting
Thomas J Webster, Brown University, United States
Title : Scientist’s computational lawyer
Julia Sidorova, Instituto Carlos III de Salud (CIBER-EHD), Spain
Title : Evaluating cell compatibility and subcutaneous host response of silk fibroin–chitosan plug composites as potential resorbable implants
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico